Autolus Therapeutics reports Q2 EPS (22c), consensus (19c)
PremiumThe FlyAutolus Therapeutics reports Q2 EPS (22c), consensus (19c)
3M ago
Autolus Therapeutics to present three clinical data updates on obe-cel
Premium
The Fly
Autolus Therapeutics to present three clinical data updates on obe-cel
5M ago
Autolus Therapeutics Shares Key FELIX Study Updates
Premium
Company Announcements
Autolus Therapeutics Shares Key FELIX Study Updates
5M ago
Autolus files to delay quarterly report, cancels earnings call
PremiumThe FlyAutolus files to delay quarterly report, cancels earnings call
6M ago
Autolus Therapeutics Announces Q1 2024 Financial Update
Premium
Company Announcements
Autolus Therapeutics Announces Q1 2024 Financial Update
6M ago
Autolus Therapeutics announces delay to Q1 earnings release, conference call
Premium
The Fly
Autolus Therapeutics announces delay to Q1 earnings release, conference call
6M ago
Autolus chairman John Johnson steps down, Mike Bonney succeeds
PremiumThe FlyAutolus chairman John Johnson steps down, Mike Bonney succeeds
7M ago
Autolus files to sell 33.33M American Depositary Shares for holders
Premium
The Fly
Autolus files to sell 33.33M American Depositary Shares for holders
7M ago
Aveo Oncology appoints Edgar Braendle as CMO
Premium
The Fly
Aveo Oncology appoints Edgar Braendle as CMO
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100